Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mukul Vij

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
The Lancet. Oncology|November 11, 2023
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective studyQinghe Zeng, Christophe Klein, Stefano Caruso, et al.
Journal of Hepatology|August 20, 2022
Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinomaJulien Calderaro, Luca Di Tommaso, Pascale Maillé, et al.
Nature Communications|December 13, 2023
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinomaJulien Calderaro, Narmin Ghaffari Laleh, Qinghe Zeng, et al.
Hepatology International|February 17, 2025
Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from AsiaAshok Choudhury, Anand V Kulkarni, Vinod Arora, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
The Lancet. Oncology|November 11, 2023
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective studyQinghe Zeng, Christophe Klein, Stefano Caruso, et al.
Journal of Hepatology|August 20, 2022
Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinomaJulien Calderaro, Luca Di Tommaso, Pascale Maillé, et al.
Nature Communications|December 13, 2023
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinomaJulien Calderaro, Narmin Ghaffari Laleh, Qinghe Zeng, et al.
Hepatology International|February 17, 2025
Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from AsiaAshok Choudhury, Anand V Kulkarni, Vinod Arora, et al.
Pageof 15